Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspect. (Q53948454)

22 May 2018

editorial

0 references

title

Unraveling resistance to trastuzumab (Herceptin): insulin-like growth factor-I receptor, a new suspect. (English)

1 reference

22 May 2018

1 reference

1 reference

2

J Baselga

1 reference

22 May 2018

J Albanell

1

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 December 2001

1 reference

22 May 2018

Journal of the National Cancer Institute

published in

1 reference

22 May 2018

volume

93

1 reference

22 May 2018

page(s)

1830-1832

1 reference

22 May 2018

issue

24

1 reference

22 May 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.24.1830

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.24.1830

1 reference

22 May 2018

PubMed ID

11752000

1 reference

22 May 2018